The Underestimated Threat—Mycobacterium Genavense Infection: A Case Report
Authors:
- Jannik SonnenbergJSJannik Sonnenberg
- Gert GabrielsGGGert Gabriels
- Ioana Diana OlaruIOIoana Diana Olaru
- Sebastian MühlSMSebastian Mühl
- Julia FischerJFJulia Fischer
- Hermann PavenstädtHPHermann Pavenstädt
- Jonel TrebickaJTJonel Trebicka
- Kai-Henrik PeifferKPKai-Henrik Peiffer
- Phil-Robin TepassePTPhil-Robin Tepasse
Open Access
- 1 June 2025
- journal article
- case report
- Published by MDPI AG in Infectious Disease Reports
- Vol. 17 (3) , 60
Abstract
Background/Objectives: Nontuberculous mycobacteria (NTM) represent a heterogeneous group of pathogens with increasing global prevalence and significant geographical variation in species distribution. NTM infections, often affecting immunocompromised individuals, are difficult to diagnose due to nonspecific clinical presentations and laboratory findings. This case study presents a rare extrapulmonary NTM infection in a 73-year-old man, initially misdiagnosed as sarcoidosis, highlighting the diagnostic and therapeutic challenges posed by such infections. Methods: The patient, a pigeon fancier, presented with recurrent fever and pancytopenia. Extensive diagnostics included blood cultures, bone marrow aspiration, and histopathology. Initial cultures and serological tests remained negative. Results: Bone marrow aspiration revealed epithelioid granulomas, initially leading to the provisional diagnosis of sarcoidosis. However, after six weeks, M. genavense was isolated from mycobacterial blood cultures from bone marrow aspirant. Antimicrobial therapy with azithromycin, rifampicin, and ethambutol was initiated. Following the initiation of appropriate antimycobacterial therapy, the patient developed immune reconstitution inflammatory syndrome (IRIS), which was managed with supportive care. The patient’s condition improved, and no further febrile episodes occurred post-treatment, marking the successful conclusion of NTM therapy. Conclusions: This case underscores the diagnostic complexity of extrapulmonary NTM infections, particularly in immunocompromised patients. Misdiagnosis can delay appropriate treatment. M. genavense, though rare, should be considered in patients with a fever of unknown origin, especially with a background of immunosuppression. Prompt mycobacterial testing and tailored antibiotic therapy are crucial to improving outcomes in NTM infections.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (493624047)
This publication has 44 references indexed in Scilit:
- Extrapulmonary nontuberculous mycobacterial infections: a guide for the general physicianClinical Medicine, 2024
- Risk Factors for Nontuberculous Mycobacterial Pulmonary DiseaseChest, 2023
- Clinical characteristics of extrapulmonary nontuberculous mycobacteria infections in comparison with pulmonary infections: A single-center, retrospective study in JapanJournal of Infection and Chemotherapy, 2023
- Nontuberculous Mycobacterium‐associated immune reconstitution inflammatory syndrome in a non‐HIV immunosuppressed patientRespirology Case Reports, 2022
- Successful treatment of rapid growing mycobacterial infections with source control alone: Case seriesIDCases, 2021
- Challenges of diagnosing and treating non-tuberculous mycobacterial pulmonary disease [NTM-PD]: A case seriesJournal of Clinical Tuberculosis and Other Mycobacterial Diseases, 2021
- Approach to the diagnosis and treatment of non-tuberculous mycobacterial diseaseJournal of Clinical Tuberculosis and Other Mycobacterial Diseases, 2021
- Modified immunohistological staining allows detection of Ziehl–Neelsen‐negative Mycobacterium tuberculosis organisms and their precise localization in human tissueThe Journal of Pathology, 2005
- Mycobacterium genavense: An emerging pathogenEuropean Journal of Clinical Microbiology & Infectious Diseases, 1994
- Disseminated "Mycobacterium genavense" infection in patients with AIDSThe Lancet, 1992